Identification of a primary biliary cirrhosis associated protein as lysosome-associated membrane protein-2

Journal of Proteomics

Volumn 91, Issue , 2013, Pages 569-579

  Wang, Lu ^a   Wang, Jingbo ^a   Shi, Yongquan ^a   Zhou, Xinmin ^a   Wang, Xuechang ^a   Li, Zengshan ^b   Huang, Xiaofeng ^b   Wang, Jianhong ^a   Han, Zheyi ^a   Li, Tingting ^c   Wang, Min ^a   Wang, Ruian ^b   Fan, Daiming ^a   Han, Ying ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c YAN'AN UNIVERSITY   (China)

Author keywords

Canalicular membrane vesicles (CMVs); Lysosome associated membrane protein 2 (LAMP 2); Monoclonal antibody 1F9 (mAb1F9); Primary biliary cirrhosis (PBC)

Indexed keywords

LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1F9; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ALTERNATIVE RNA SPLICING; ANTIBODY ISOLATION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MEMBRANE VESICLE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

4′,6-DIAMIDINO-2-PHENYLINDOLE; AE2; AMA; ANION EXCHANGER 2; ANTI-MITOCHONDRIA ANTIBODY; BILE SALT EXPORT PUMP; BSEP; CANALICULAR MEMBRANE VESICLES; CANALICULAR MEMBRANE VESICLES (CMVS); CMVS; DAPI; HBV; HEPATITIS B VIRUS; LAMP-1; LAMP-2; LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 2; LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 2 (LAMP-2); MAB1F9; MAB1F9 ANTIGEN; MAB1F9-AG; MALDI-TOF/TOF; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION/IONIZATION-TANDEM TIME-OF-FLIGHT ANALYSIS; MDR1; MDR3; MONOCLONAL ANTIBODY 1F9; MONOCLONAL ANTIBODY 1F9 (MAB1F9); MRP2; MS; MULTIDRUG RESISTANT PROTEIN 2; MULTIPLE DRUG RESISTANT PROTEIN 1; MULTIPLE DRUG RESISTANT PROTEIN 3; PBC; PBS; PEPTIDE MASS FINGERPRINTING; PFIC2; PHOSPHATE BUFFER SALINE; PMF; PRIMARY BILIARY CIRRHOSIS; PRIMARY BILIARY CIRRHOSIS (PBC); PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 2; REAL-TIME POLYMERASE CHAIN REACTION; RT-PCR; SDS-PAGE; SJÖGREN'S SYNDROME; SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL ELECTROPHORESIS; SS; UDCA; URSODEOXYCHOLIC ACID;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; CELL DIFFERENTIATION; DOGS; GENE EXPRESSION REGULATION; HUMANS; HYBRIDOMAS; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MADIN DARBY CANINE KIDNEY CELLS; MOLECULAR SEQUENCE DATA; PROGNOSIS; PROTEIN BINDING; RECOMBINANT PROTEINS; RNA, MESSENGER; TISSUE DISTRIBUTION; URSODEOXYCHOLIC ACID;

EID: 84884400221     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.08.019     Document Type: Article

References (43)

1. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
2. Talwalkar J.A., Lindor K.D. Primary biliary cirrhosis. Lancet 2003, 362:53-61.
3. Gong Y., Gluud C. Colchicine for primary biliary cirrhosis. Cochrane Database Syst Rev 2004, CD004481.
4. Hendrickse M.T., Rigney E., Giaffer M.H., Soomro I., Triger D.R., Underwood J.C., et al. Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial. Gastroenterology 1999, 117:400-407.
5. Dickson E.R., Fleming T.R., Wiesner R.H., Baldus W.P., Fleming C.R., Ludwig J., et al. Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med 1985, 312:1011-1015.
6. Beuers U., Spengler U., Zwiebel F.M., Pauletzki J., Fischer S., Paumgartner G. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology 1992, 15:603-608.
7. Zegers M.M., Hoekstra D. Sphingolipid transport to the apical plasma membrane domain in human hepatoma cells is controlled by PKC and PKA activity: a correlation with cell polarity in HepG2 cells. J Cell Biol 1997, 138:307-321.
8. Jansen P.L., Muller M. Early events in sepsis-associated cholestasis. Gastroenterology 1999, 116:486-488.
9. Strautnieks S.S., Byrne J.A., Pawlikowska L., Cebecauerova D., Rayner A., Dutton L., et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 2008, 134:1203-1214.
10. Kartenbeck J., Leuschner U., Mayer R., Keppler D. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996, 23:1061-1066.
11. Shoda J., Kano M., Oda K., Kamiya J., Nimura Y., Suzuki H., et al. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am J Gastroenterol 2001, 96:3368-3378.
12. Zollner G., Fickert P., Zenz R., Fuchsbichler A., Stumptner C., Kenner L., et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 2001, 33:633-646.
13. Zollner G., Fickert P., Silbert D., Fuchsbichler A., Marschall H.U., Zatloukal K., et al. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol 2003, 38:717-727.
14. Takeyama Y., Uehara Y., Inomata S., Morihara D., Nishizawa S., Ueda S., et al. Alternative transporter pathways in patients with untreated early-stage and late-stage primary biliary cirrhosis. Liver Int 2009, 29:406-414.
15. Kojima H., Nies A.T., Konig J., Hagmann W., Spring H., Uemura M., et al. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J Hepatol 2003, 39:693-702.
16. Prieto J., Qian C., Garcia N., Diez J., Medina J.F. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 1993, 105:572-578.
17. Medina J.F., Martínez-Ansó E., Vázquez J.J., Prieto J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 1997, 25:12-17.
18. Salas J.T., Banales J.M., Sarvide S., Recalde S., Ferrer A., Uriarte I., et al. Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 2008, 134:1482-1493.
19. Vazquez J.J., Vazquez M., Idoate M.A., Montuenga L., Martinez-Anso E., Castillo J.E., et al. Anion exchanger immunoreactivity in human salivary glands in health and Sjogren's syndrome. Am J Pathol 1995, 146:1422-1432.
20. Mazzone A., Tietz P., Jefferson J., Pagano R., LaRusso N.F. Isolation and characterization of lipid microdomains from apical and basolateral plasma membranes of rat hepatocytes. Hepatology 2006, 43:287-296.
21. Wang L., Wang J., Zhou X., Li J., Shi Y., Han Z., et al. CM2 antigen, a potential novel molecule participating in glucuronide transport on rat hepatocyte canalicular membrane. Eur J Histochem 2012, 56:e26.
22. Yue Q.X., Cao Z.W., Guan S.H., Liu X.H., Tao L., Wu W.Y., et al. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol Cell Proteomics 2008, 7:949-961.
23. Chen Z., Zeng M., Song B., Hou C., Hu D., Li X., et al. Dufulin activates HrBP1 to produce antiviral responses in tobacco. PLoS One 2012, 7:e37944.
24. Eskelinen E.-L., Cuervo A.M., Taylor M.R.G., Nishino I., Blum J.S., Dice J.F., et al. Unifying nomenclature for the isoforms of the lysosomal membrane protein LAMP-2. Traffic 2005, 6:1058-1061.
25. Carlsson S.R., Roth J., Piller F., Fukuda M. Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycan. J Biol Chem 1988, 263:18911-18919.
26. Hatem C.L., Gough N.R., Fambrough D.M. Multiple mRNAs encode the avian lysosomal membrane protein LAMP-2, resulting in alternative transmembrane and cytoplasmic domains. J Cell Sci 1995, 108(Pt 5):2093-2100.
27. Akasaki K., Michihara A., Fujiwara Y., Mibuka K., Tsuji H. Biosynthetic transport of a major lysosome-associated membrane glycoprotein 2, Lamp-2: a significant fraction of newly synthesized Lamp-2 is delivered to lysosomes by way of early endosomes. J Biochem 1996, 120:1088-1094.
28. Schroder B., Wrocklage C., Pan C., Jager R., Kosters B., Schafer H., et al. Integral and associated lysosomal membrane proteins. Traffic 2007, 8:1676-1686.
29. Furuta K., Yang X.-L., Chen J.-S., Hamilton S.R., August J.T. Differential expression of the lysosome-associated membrane proteins in normal human tissues. Arch Biochem Biophys 1999, 365:75-82.
30. Kain R., Exner M., Brandes R., Ziebermayr R., Cunningham D., Alderson C.A., et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008, 14:1088-1096.
31. Sawada R., Lowe J.B., Fukuda M. E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J Biol Chem 1993, 268:12675-12681.
32. Tanaka Y., Guhde G., Suter A., Eskelinen E.-L., Hartmann D., Lullmann-Rauch R., et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 2000, 406:902-906.
33. Zhou D., Li P., Lin Y., Lott J.M., Hislop A.D., Canaday D.H., et al. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 2005, 22:571-581.
34. Gershwin M.E., Ansari A.A., Mackay I.R., Nakanuma Y., Nishio A., Rowley M.J., et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000, 174:210-225.
35. Miyakawa H., Tanaka A., Kikuchi K., Matsushita M., Kitazawa E., Kawaguchi N., et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001, 34:243-248.
36. Goldfischer S., Popper H., Sternlieb I. The significance of variations in the distribution of copper in liver disease. Am J Pathol 1980, 99:715-730.
37. Tsianos E.V., Hoofnagle J.H., Fox P.C., Alspaugh M., Jones E.A., Schafer D.F., et al. Sjogren's syndrome in patients with primary biliary cirrhosis. Hepatology 1990, 11:730-734.
38. Hatzis G.S., Fragoulis G.E., Karatzaferis A., Delladetsima I., Barbatis C., Moutsopoulos H.M. Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome. J Rheumatol 2008, 35:2012-2016.
39. Selmi C., Meroni P.L., Gershwin M.E. Primary biliary cirrhosis and Sjogren's syndrome: autoimmune epithelitis. J Autoimmun 2012, 39:34-42.
40. Dawson P.A., Lan T., Rao A. Bile acid transporters. J Lipid Res 2009, 50:2340-2357.
41. Schneede A., Schmidt C.K., Hölttä-Vuori M., Heeren J., Willenborg M., Blanz J., et al. Role for LAMP-2 in endosomal cholesterol transport. J Cell Mol Med 2011, 15:280-295.
42. Wakabayashi Y., Dutt P., Lippincott-Schwartz J., Arias I.M. Rab11a and myosin Vb are required for bile canalicular formation in WIF-B9 cells. Proc Natl Acad Sci U S A 2005, 102:15087-15092.
43. Jazrawi R.P., de Caestecker J.S., Goggin P.M., Britten A.J., Joseph A.E., Maxwell J.D., et al. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 1994, 106:134-142.